Renal Pelvis Carcinoma — Trials

Renal Pelvis Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

38 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 4
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04398368	Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study	terminated	Phase 2	25	Mayo ClinicOTHER	1	Aug 8, 2023	clinicaltrials
NCT03397394	Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma(ATLAS)	terminated	Phase 2	97	pharmaand GmbHINDUSTRY	6	Jun 9, 2023